Suppr超能文献

乙型肝炎病毒表面抗原(HBsAg)在毕赤酵母中的表达、纯化及特性分析

Expression, purification, and characterization of hepatitis B virus surface antigens (HBsAg) in yeast Pichia Pastoris.

作者信息

Liu Rushi, Lin Qinlu, Sun Yi, Lu Xiangyang, Qiu Yilan, Li Ye, Guo Xiangrong

机构信息

College of Life Sciences, Hunan Normal University, Changsha 410081, China.

出版信息

Appl Biochem Biotechnol. 2009 Aug;158(2):432-44. doi: 10.1007/s12010-009-8527-x. Epub 2009 Jan 29.

Abstract

Prevention of the prevalence of HB depends upon the development of efficient diagnostic reagent and preventive vaccine. Pichia pastoris offers many advantages over the other expression systems in the production of recombinant HBsAg. In this study, we reported that the recombinant P. pastoris strains were cultured in shake flasks and then scaled up in a 5.0-l bioreactor: approximately 27 mg/l of the protein and the maximal cell OD at 600 nm of 310 were achieved in the bioreactor. The recombinant HBsAg was purified by three steps of purification procedures. SDS-PAGE showed that the purified recombinant HBsAg constituted only one homogeneous band of approximately 24 kDa. CsCl density gradient ultracentrifugation assay indicated that the density of the HBsAg was 1.2 mg/ml, which was in agreement with the natural HBsAg, the HBsAg expressed in Saccharomyces cerevisiae and in mammalian cells. Electron microscope observation revealed that the purified recombinant HBsAg was homogeneous 22-nm particles, suggesting the HBsAg expressed in P. pastoris was self-assembled to virus-like structures. Competitive ELISA indicated that P. pastoris-derived HBsAg possessed the excellent immunoreaction with anti-HBsAg. Animal immunization showed that the immunogenicity of P. pastoris-derived HBsAg was superior to that of S. cerevisiae-derived HBsAg. Together, our results demonstrated that the recombinant HBsAg expressed in P. pastoris could provide promising, inexpensive, and large-scale materials for the diagnostic reagent and vaccine to prevent HBV infection.

摘要

预防乙肝的流行取决于高效诊断试剂和预防性疫苗的研发。在生产重组乙肝表面抗原(HBsAg)方面,毕赤酵母相较于其他表达系统具有诸多优势。在本研究中,我们报道了重组毕赤酵母菌株先在摇瓶中培养,然后在5.0升生物反应器中进行放大培养:在生物反应器中实现了约27毫克/升的蛋白产量以及600纳米处最大细胞光密度值为310。重组HBsAg通过三步纯化程序进行纯化。十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳(SDS - PAGE)显示,纯化后的重组HBsAg仅构成一条约24千道尔顿的单一均一条带。氯化铯密度梯度超速离心分析表明,HBsAg的密度为1.2毫克/毫升,这与天然HBsAg、在酿酒酵母和哺乳动物细胞中表达的HBsAg一致。电子显微镜观察显示,纯化后的重组HBsAg是均匀的22纳米颗粒,表明在毕赤酵母中表达的HBsAg可自组装成病毒样结构。竞争性酶联免疫吸附测定(ELISA)表明,毕赤酵母来源的HBsAg与抗HBsAg具有良好的免疫反应。动物免疫表明,毕赤酵母来源的HBsAg的免疫原性优于酿酒酵母来源的HBsAg。总之,我们的结果表明,在毕赤酵母中表达的重组HBsAg可为预防乙肝病毒(HBV)感染的诊断试剂和疫苗提供有前景、低成本且大规模的材料。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验